PT1131050E - Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar - Google Patents

Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar

Info

Publication number
PT1131050E
PT1131050E PT00964295T PT00964295T PT1131050E PT 1131050 E PT1131050 E PT 1131050E PT 00964295 T PT00964295 T PT 00964295T PT 00964295 T PT00964295 T PT 00964295T PT 1131050 E PT1131050 E PT 1131050E
Authority
PT
Portugal
Prior art keywords
mouth
preparation
galense
formulations
mixture
Prior art date
Application number
PT00964295T
Other languages
English (en)
Inventor
Claude Laruelle
Rene Gimet
No L Zakarian
Dominique Toselli
Original Assignee
Cll Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cll Pharma filed Critical Cll Pharma
Publication of PT1131050E publication Critical patent/PT1131050E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT00964295T 1999-09-15 2000-09-15 Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar PT1131050E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9911513A FR2798289B1 (fr) 1999-09-15 1999-09-15 Formes galeniques a delitement rapide en bouche et leur procede de preparation

Publications (1)

Publication Number Publication Date
PT1131050E true PT1131050E (pt) 2004-11-30

Family

ID=9549849

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00964295T PT1131050E (pt) 1999-09-15 2000-09-15 Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar

Country Status (18)

Country Link
US (1) US6669957B1 (pt)
EP (1) EP1131050B8 (pt)
JP (1) JP2003509353A (pt)
KR (1) KR100854033B1 (pt)
AT (1) ATE267581T1 (pt)
AU (1) AU7526300A (pt)
BR (1) BR0007151A (pt)
CA (1) CA2350675A1 (pt)
DE (1) DE60011036T2 (pt)
ES (1) ES2222234T3 (pt)
FR (1) FR2798289B1 (pt)
HU (1) HUP0104914A3 (pt)
MA (1) MA25323A1 (pt)
MX (1) MX229299B (pt)
PL (1) PL200672B1 (pt)
PT (1) PT1131050E (pt)
WO (1) WO2001019336A1 (pt)
ZA (1) ZA200103280B (pt)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) * 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
GB0226076D0 (en) 2002-11-08 2002-12-18 Rp Scherer Technologies Inc Improved formulations containing substituted imidazole derivatives
FI20022007A0 (fi) * 2002-11-08 2002-11-08 Juvantia Pharma Ltd Oy Oromukosaalinen valmiste ja menetelmä sen valmistamiseksi
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
GB2411355B (en) 2004-02-27 2006-02-22 Niche Generics Ltd Pharmaceutical composition
US20050220873A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate and controlled release properties that contain a GABAB receptor agonist
US8007827B2 (en) * 2004-04-02 2011-08-30 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties
US20050220874A1 (en) * 2004-04-02 2005-10-06 Chien-Hsuan Han Pharmaceutical dosage forms having immediate release and controlled release properties that contain a GABAB receptor agonist
US20050226927A1 (en) * 2004-04-02 2005-10-13 Impax Laboratories, Inc. Pharmaceutical dosage forms having immediate release and/or controlled release properties that contain a GABAB receptor agonist
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
JP5112619B2 (ja) * 2004-05-20 2013-01-09 大塚製薬株式会社 固形医薬製剤
TWI338583B (en) * 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
WO2006135491A2 (en) * 2005-06-08 2006-12-21 Basf Aktiengesellschaft Medicament carrier composition and method of forming a film therefrom
CN101277701A (zh) * 2005-09-30 2008-10-01 贝林格尔·英格海姆维特梅迪卡有限公司 含有美洛昔康的药物制剂
US7811604B1 (en) 2005-11-14 2010-10-12 Barr Laboratories, Inc. Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same
GB2443793B (en) * 2006-04-05 2010-12-01 Reckitt Benckiser Healthcare Product, method of manufacture and use
CA2705884A1 (en) * 2007-11-14 2009-05-22 Manuel Gidekel New extracts of deschampsia antarctica desv. with antineoplastic activity
WO2010104563A2 (en) 2009-03-09 2010-09-16 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
DK2488145T3 (da) * 2009-10-12 2024-07-22 Boehringer Ingelheim Vetmedica Gmbh Beholdere til sammensætninger omfattende meloxicam
EP2314296A1 (en) * 2009-10-22 2011-04-27 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Orally Disintegrating Tablets of Betahistine
BR112012022073A2 (pt) 2010-03-03 2017-10-31 Boehringer Ingelheim Vetmedica Gmbh uso de meloxicam para o tratamento de longa duração de distúrbios musculoesqueletais em gatos.
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
PT3069733T (pt) * 2013-11-13 2022-11-09 National Defense Education And Res Foundation Nova composição de composto de acetaminofeno sem efeito secundário para o fígado
JP6858729B2 (ja) * 2018-05-25 2021-04-14 ▲財▼▲団▼法人国防教育研究基金会Ｎａｔｉｏｎａｌ Ｄｅｆｅｎｓｅ Ｅｄｕｃａｔｉｏｎ Ａｎｄ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ 肝臓に対する副作用がない、新しいアセトアミノフェン複合組成
FR3099881B1 (fr) 2019-08-13 2022-08-26 Ethypharm Sa Comprimé orodispersible d’opioide à faible dosage et son procédé de préparation.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH26730A (en) * 1988-12-30 1992-09-28 Ciba Geigy Ag Coated adhesive tablets
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
DE69728857T3 (de) * 1996-02-09 2010-02-18 Quadrant Drug Delivery Ltd., Ruddington Feste arzneimittel enthaltend trehalose
AR017512A1 (es) * 1997-08-22 2001-09-12 Smithkline Beecham Corp Tabletas de metilcelulosa rapidamente desintegrables para administracion por via oral y procedimiento para prepararlas
US6465009B1 (en) * 1998-03-18 2002-10-15 Yamanouchi Pharmaceutical Co., Ltd. Water soluble polymer-based rapidly dissolving tablets and production processes thereof

Also Published As

Publication number Publication date
EP1131050B1 (fr) 2004-05-26
DE60011036D1 (de) 2004-07-01
KR100854033B1 (ko) 2008-08-26
WO2001019336A1 (fr) 2001-03-22
US6669957B1 (en) 2003-12-30
BR0007151A (pt) 2001-08-14
ATE267581T1 (de) 2004-06-15
PL347693A1 (en) 2002-04-22
MX229299B (es) 2005-07-20
CA2350675A1 (fr) 2001-03-22
KR20010089883A (ko) 2001-10-12
ZA200103280B (en) 2001-10-25
ES2222234T3 (es) 2005-02-01
EP1131050A1 (fr) 2001-09-12
DE60011036T2 (de) 2005-06-23
HUP0104914A2 (hu) 2002-07-29
FR2798289B1 (fr) 2004-12-31
HUP0104914A3 (en) 2003-05-28
AU7526300A (en) 2001-04-17
FR2798289A1 (fr) 2001-03-16
EP1131050B8 (fr) 2004-11-10
MA25323A1 (fr) 2001-12-31
PL200672B1 (pl) 2009-01-30
JP2003509353A (ja) 2003-03-11

Similar Documents

Publication Publication Date Title
PT1131050E (pt) Formulacoes galenicas que se desintegram rapidamente na boca e metodo para as preparar
DE60121570D1 (de) Oral anzuwendende schnell zerfallende feste darreichungsformen
AR010704A1 (es) Composiciones farmaceuticas en forma de particulas que comprenden tetrahidrolipstatina, un estabilizante y un excipiente
BRPI0406996A (pt) Formas de dosagem sólida via transmucosa oral sem açúcar e sua utilização
WO2001041770A3 (en) Nanoparticulate eplerenone compositions
DE69425932D1 (de) Schnellauflösliche pharmazeutische Dosierungsformen und Verfahren zu ihrer Herstellung
CO5190672A1 (es) Composicion para la dosificacion oral, de disolucion instantanea
WO2004000197A3 (en) Quick dissolve compositions and tablets based thereon
ATE200981T1 (de) Arzneizubereitung enthaltend amoxycillin und kaliumclavunalat
RS50303B (sr) Farmaceutska kompozicija nimesulida sa kontrolisanim oslobađanjem
AR013117A1 (es) Una composicion farmaceutica solida en forma de comprimido que comprende un derivado de benzofurano con actividad antiarritmica adaptada para administracion oral
CO5160287A1 (es) Formulacion de liberacion controlada de divalproex sodico
HK1067299A1 (en) Pharmaceutical compositions containing terbinafineand use thereof
AR011919A1 (es) FORMULACIoN EN COMPRIMIDOS O CÁPSULAS PARA TRAGAR DE PARACETAMOL (N-ACETIL-P-AMINOFENOL) Y PROCEDIMIENTO PARA PREPARARLA
WO2002024203A3 (en) Controlled release formulations for oral administration
WO2002011694A3 (en) COMPOSITIONS AND DOSAGE FORMS FOR APPLICATION IN ORAL CAVITY IN THE TREATMENT OF MYCOSIS
BR0013719A (pt) Dosagem oral de liberaçâo controlada, apropriada para administração oral
ES2099021B1 (es) Composicion farmaceutica que tiene actividad analgesica.
MXPA06000332A (es) Nueva composicion farmaceutica solida que comprende amisulprida.
YU66202A (sh) Sistem za kontrolisano otpuštanje ciprofloksacina nakon oralne primene u jednoj dnevnoj dozi
ATE344026T1 (de) Pharmazeutische formulierung mit einem nichtpeptidischen renin-hemmer und surfactant
AR034435A1 (es) Agentes terapeuticos.
HK1045937A1 (en) Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof
GEP20043377B (en) Pharmaceutical Complex
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung